跳至主要内容
临床试验/NCT03727399
NCT03727399Enrolling By Invitation不适用

Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients

Mabylon AG1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
300
试验地点
1
主要终点
Antibody profiling

研究概览

简要总结

The project examines the hypothesis that monoclonal allergen-neutralizing antibodies can be recombinantly produced from B lymphocytes isolated from pollen allergic patients. Patient samples suitable for antibody cloning are selected based on seroprofiling for the respective allergens. The study aims at isolating lymphocytes from patients with potential allergen-neutralizing IgG in serum and to clone antibodies from antibody gene sequences obtained from B cells of those patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of allergic rhinitis, conjunctivitis or asthma due to sensitization to grass- or birch Allergens
  • Male or female patients older than 18 years
  • Written informed consent for providing blood and also to allow experimental manipulation

排除标准

  • Age < 18 years
  • Any corticosteroids within the last three days
  • Oral corticosteroid therapy within the last ten days
  • Parenteral depot corticosteroids within the last three months

结局指标

主要结局

Antibody profiling

时间窗: October 2018 - September 2021

Analysis and IgG profiling of specific antibodies binding major grass- and tree-pollen allergens in allergic patients.

次要结局

未报告次要终点

研究者

发起方
Mabylon AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验